drugset / Trial / NCT00620373

Molecular Breast Imaging as a Screening Tool for Women With Dense Breasts

NCT00620373

NaSingle-groupSingle-blindDiagnostic

Summary

We aim to compare the sensitivity of mammography to the sensitivity of Molecular Breast Imaging (a new gamma-camera based breast imaging technology) in women with dense breast tissue who are at increased risk for breast cancer.

Timeline

Start
2005-08
Primary completion
2010-06
Completion
2010-06

Drugs

EvaluationDrugModalityDoseRoute
Background TECHNETIUM SESTAMIBI Diagnostic / imaging agent 740 mbq Other

Indications